Cargando…

Pyroptosis-Related Signature Predicts the Progression of Ulcerative Colitis and Colitis-Associated Colorectal Cancer as well as the Anti-TNF Therapeutic Response

Ulcerative colitis (UC) is a complex intestinal inflammation with an increasing risk of colitis-associated colorectal cancer (CAC). However, the pathogenesis is still unclear between active UC and inactive UC. Recently, it has been reported that pyroptosis-related genes (PRGs) are closely associated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ning, Yumei, Lin, Kun, Fang, Jun, Chen, Xiaojia, Hu, Xinyi, Liu, Lan, Zhao, Qiu, Wang, Haizhou, Wang, Fan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897931/ https://www.ncbi.nlm.nih.gov/pubmed/36741232 http://dx.doi.org/10.1155/2023/7040113

Ejemplares similares

Pectic polysaccharides ameliorate the pathology of ulcerative colitis in mice by reducing pyroptosis
por: Cui, Lu-Jia, et al.
Publicado: (2022)

Identification of Pharmacological Autophagy Regulators of Active Ulcerative Colitis
por: Qiu, Peishan, et al.
Publicado: (2021)

Identification and exploration of pharmacological pyroptosis-related biomarkers of ulcerative colitis
por: Chen, Kaiwei, et al.
Publicado: (2022)

Roles of macrophages on ulcerative colitis and colitis-associated colorectal cancer
por: Zhang, Maorun, et al.
Publicado: (2023)

Well-differentiated adenocarcinoma associated with ulcerative colitis
por: Yamamoto, Tomoko, et al.
Publicado: (2017)

Disease clearance in ulcerative colitis: Setting the therapeutic goals for future in the treatment of ulcerative colitis
por: Ramos, Laura, et al.
Publicado: (2023)

Epigenetic Signatures Discriminate Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis From Patients With Ulcerative Colitis
por: de Krijger, Manon, et al.
Publicado: (2022)

Transcriptional Signatures That Define Ulcerative Colitis in Remission
por: Fenton, Christopher G, et al.
Publicado: (2020)

Clinical features and surgical selection in colitis-associated colorectal cancer with ulcerative colitis
por: Kuwahara, Ryuichi, et al.
Publicado: (2023)

Piperlongumine Alleviates Mouse Colitis and Colitis-Associated Colorectal Cancer
por: Huang, Jia-Rong, et al.
Publicado: (2020)

Shared biomarkers and immune cell infiltration signatures in ulcerative colitis and nonalcoholic steatohepatitis
por: Wang, Wenxin, et al.
Publicado: (2023)

Colorectal Dysplasia and Cancer Surveillance in Ulcerative Colitis
por: Reznicek, Emily, et al.
Publicado: (2021)

ULCERATIVE COLITIS
Publicado: (1969)

Serum miRNA signature diagnoses and discriminates murine colitis subtypes and predicts ulcerative colitis in humans
por: Viennois, Emilie, et al.
Publicado: (2017)

Colorectal Cancer in Ulcerative Colitis: Mechanisms, Surveillance and Chemoprevention
por: Li, Wenqian, et al.
Publicado: (2022)

Taurine Attenuates Carcinogenicity in Ulcerative Colitis-Colorectal Cancer Mouse Model
por: Wang, Guifeng, et al.
Publicado: (2020)

The therapeutic potential of stem cell-derived exosomes in the ulcerative colitis and colorectal cancer
por: Guo, Gang, et al.
Publicado: (2022)

Pediatric Ulcerative Colitis: The Therapeutic Road to Infliximab
por: Puthoor, Pamela R., et al.
Publicado: (2013)

Therapeutic Potential of Proanthocyanidins in Ulcerative Colitis in Remission
por: Głąbska, Dominika, et al.
Publicado: (2020)

Gaseous metabolites as therapeutic targets in ulcerative colitis
por: Yao, Chu K, et al.
Publicado: (2023)

A review of the therapeutic management of ulcerative colitis
por: Aslam, Nasar, et al.
Publicado: (2022)

Alicaforsen: An Emerging Therapeutic Agent for Ulcerative Colitis and Refractory Pouchitis
por: Hosten, Terron Anthony, et al.
Publicado: (2014)

Carboxypeptidase A6 was identified and validated as a novel potential biomarker for predicting the occurrence of active ulcerative colitis
por: Wang, Haizhou, et al.
Publicado: (2020)

Early detection of ulcerative colitis-associated colorectal cancer
por: Zhen, Yu, et al.
Publicado: (2018)

Molecular characterization of ulcerative colitis-associated colorectal carcinomas
por: Hirsch, Daniela, et al.
Publicado: (2020)

Was ulcerative colitis one of the risk factors of colorectal cancer?
por: Guo, Qiaoqiao, et al.
Publicado: (2022)

Biologics in the management of ulcerative colitis – comparative safety and efficacy of TNF-α antagonists
por: Fausel, Rebecca, et al.
Publicado: (2015)

Anti-TNF-Related Leukocytoclastic Vasculitis in Ulcerative Colitis: A Case Report
por: Giorgio, Valentina, et al.
Publicado: (2021)

Infliximab in ulcerative colitis
por: Levin, Avi, et al.
Publicado: (2008)

Ulcerative Colitis in Infancy
por: Rukunuzzaman, Md, et al.
Publicado: (2011)

Management of ulcerative colitis
por: Fell, John M, et al.
Publicado: (2016)

Chronic Ulcerative Colitis
por: Sen, S. C.
Publicado: (1939)

Chronic Ulcerative Colitis
por: Chopra, R. N., et al.
Publicado: (1939)

Mitochondria in Ulcerative Colitis
por: Stange, Eduard F.
Publicado: (2021)

Natural compounds as safe therapeutic options for ulcerative colitis
por: Gupta, Mukta, et al.
Publicado: (2022)

Disease clearance in ulcerative colitis: Is the ultimate therapeutic target?
por: D’Amico, Ferdinando, et al.
Publicado: (2023)

Functional Comparison between Genes Dysregulated in Ulcerative Colitis and Colorectal Carcinoma
por: Zhao, Wenyuan, et al.
Publicado: (2013)

Inhibiting Ferroptosis: A Novel Approach for Ulcerative Colitis Therapeutics
por: Huang, Jinke, et al.
Publicado: (2022)

Identifying neutrophil-associated subtypes in ulcerative colitis and confirming neutrophils promote colitis-associated colorectal cancer
por: Zhang, Chen, et al.
Publicado: (2023)

PSMB5 Alleviates Ulcerative Colitis by Inhibiting ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis
por: Han, Liang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1ad3ou6q9envjgac2tan6582nb